Dr. Raymond M. Pertusi is a Clinical Associate Professor of Medicine at UTMB. He joined the UTMB faculty in 2014 from UMASS Memorial / UMASS Medical School in Worcester, MA. Prior to that, he held positions as Chief of Rheumatology at Harvard Vanguard Medical Associates in Boston, Massachusetts; where he was an associate physician at Brigham and Women's Hospital, and University of North Texas Health Science center in Fort Worth. He trained in rheumatology at Seaton Hall University Post Graduate School of Medicine / Saint Michael's Medical Center. He is Board-certified in internal medicine and rheumatology.
Dr. Pertusi has published several articles in peer-reviewed journals. He has also contributed to textbook chapters. He has served as principal investigator in a few research studies and co-investigator in many studies. His interests include general rheumatology and non-narcotic pain management. He is a fellow of the American College of Physicians, and a fellow of the American College of Rheumatology.
New York Institute of Technology College of Osteopathic Medicine - Old Westbury, NY, DO, 1983
Rotating Medical, Saddle Brook Hospital - Saddle Brook, NJ, 1984
Internal Medicine, Saint Michael's Medical Center - Newark, NJ, 1987
Rheumatology, Saint Michael's Medical Center - Newark, NJ, 1989
2660 Gulf Freeway South Entrance B
League City, TX 77573
Fax: (281) 337-0704
400 Harborside Drive Suite 100
Galveston, TX 77555
Fax: (409) 747-7014
Why do some providers have no ratings?
A provider may have no ratings for several reasons. A provider's ratings are only posted when she/he has a minimum of 30 completed surveys within the past twelve months. New-to-UTMB providers or individuals in less common areas of practice may be temporarily under this threshold. Also, the UTMB Health provider directory includes listings for independent community physicians and other health care providers who serve patients in our facilities. Ratings for these individuals, who are part of their own private practices, are not currently available to us.
Read more about Ratings and Comments